Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01663857
Title A Study of LY2228820 for Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

Ralimetinib

Carboplatin + Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.